516 related articles for article (PubMed ID: 14724437)
21. Liver Transplantation for Hereditary Transthyretin Amyloidosis: After 20 Years Still the Best Therapeutic Alternative?
Ericzon BG; Wilczek HE; Larsson M; Wijayatunga P; Stangou A; Pena JR; Furtado E; Barroso E; Daniel J; Samuel D; Adam R; Karam V; Poterucha J; Lewis D; Ferraz-Neto BH; Cruz MW; Munar-Ques M; Fabregat J; Ikeda S; Ando Y; Heaton N; Otto G; Suhr O
Transplantation; 2015 Sep; 99(9):1847-54. PubMed ID: 26308415
[TBL] [Abstract][Full Text] [Related]
22. Liver transplantation and anemia in familial amyloidosis ATTR V30M.
Beirão I; Lobato L; Costa PM; Fonseca I; Silva M; Bravo F; Cabrita A; Porto G
Amyloid; 2007 Mar; 14(1):33-7. PubMed ID: 17453623
[TBL] [Abstract][Full Text] [Related]
23. Impact of liver transplantation on familial amyloidotic polyneuropathy (FAP) patients' symptoms and complications.
Suhr OB
Amyloid; 2003 Aug; 10 Suppl 1():77-83. PubMed ID: 14640045
[TBL] [Abstract][Full Text] [Related]
24. New therapeutic approaches for familial amyloidotic polyneuropathy (FAP).
Ando Y
Amyloid; 2003 Aug; 10 Suppl 1():55-66. PubMed ID: 14640043
[TBL] [Abstract][Full Text] [Related]
25. [Application to transthyretin analysis].
Ueda M; Ando Y
Rinsho Byori; 2006 Jun; 54(6):601-8. PubMed ID: 16872010
[TBL] [Abstract][Full Text] [Related]
26. [Gene therapy in familial amyloidotic polyneuropathy by single-stranded oligonucleotides (SSOs)].
Nakamura M; Ando Y
Rinsho Byori; 2004 Oct; 52(10):804-12. PubMed ID: 15624495
[TBL] [Abstract][Full Text] [Related]
27. [Diagnosis of familial amyloid polyneuropathy type I in Argentina].
Pérez G; Romero MC; Trigo P; Lendoire J; Imventarza O; Nesse A
Medicina (B Aires); 2008; 68(4):273-81. PubMed ID: 18786882
[TBL] [Abstract][Full Text] [Related]
28. The long-term impact of liver transplantation on kidney function in familial amyloidotic polyneuropathy patients.
Nowak G; Suhr OB; Wikström L; Wilczek H; Ericzon BG
Transpl Int; 2005 Jan; 18(1):111-5. PubMed ID: 15612992
[TBL] [Abstract][Full Text] [Related]
29. Ocular amyloid angiopathy associated with familial amyloidotic polyneuropathy caused by amyloidogenic transthyretin Y114C.
Kawaji T; Ando Y; Nakamura M; Yamashita T; Wakita M; Ando E; Hirata A; Tanihara H
Ophthalmology; 2005 Dec; 112(12):2212. PubMed ID: 16225929
[TBL] [Abstract][Full Text] [Related]
30. Liver transplantation for familial amyloid polyneuropathy non-VAL30MET variants: are cardiac complications influenced by prophylactic pacing and immunosuppressive weaning?
Lauro A; Diago Usò T; Masetti M; Di Benedetto F; Cautero N; De Ruvo N; Dazzi A; Quintini C; Begliomini B; Siniscalchi A; Ramacciato G; Risaliti A; Miller CM; Pinna AD
Transplant Proc; 2005 Jun; 37(5):2214-20. PubMed ID: 15964382
[TBL] [Abstract][Full Text] [Related]
31. Liver transplantation in transthyretin amyloidosis: issues and challenges.
Carvalho A; Rocha A; Lobato L
Liver Transpl; 2015 Mar; 21(3):282-92. PubMed ID: 25482846
[TBL] [Abstract][Full Text] [Related]
32. Cardiac amyloid in patients with familial amyloid polyneuropathy consists of abundant wild-type transthyretin.
Yazaki M; Tokuda T; Nakamura A; Higashikata T; Koyama J; Higuchi K; Harihara Y; Baba S; Kametani F; Ikeda S
Biochem Biophys Res Commun; 2000 Aug; 274(3):702-6. PubMed ID: 10924339
[TBL] [Abstract][Full Text] [Related]
33. Results of liver transplantation for familial amyloid polyneuropathy type I in Brazil.
Bittencourt PL; Couto CA; Farias AQ; Marchiori P; Bosco Massarollo PC; Mies S
Liver Transpl; 2002 Jan; 8(1):34-9. PubMed ID: 11799483
[TBL] [Abstract][Full Text] [Related]
34. Familial amyloidotic polyneuropathy and transthyretin.
Nagasaka T
Subcell Biochem; 2012; 65():565-607. PubMed ID: 23225017
[TBL] [Abstract][Full Text] [Related]
35. Effect of recipient-derived cells on the progression of familial amyloidotic polyneuropathy after liver transplantation: a retrospective study.
Ohya Y; Jono H; Nakamura M; Hayashida S; Ueda M; Obayashi K; Misumi S; Asonuma K; Ando Y; Inomata Y
Ann Clin Biochem; 2010 Nov; 47(Pt 6):529-34. PubMed ID: 20930032
[TBL] [Abstract][Full Text] [Related]
36. [Analyses of amyloid formation mechanism in familial amyloidotic polyneuropathy and therapeutic trial].
Ando Y
Rinsho Byori; 2000 May; 48(5):425-9. PubMed ID: 10892290
[TBL] [Abstract][Full Text] [Related]
37. Long-term quantitative evaluation of liver transplantation in familial amyloid polyneuropathy (Portuguese V30M).
de Carvalho M; Conceição I; Bentes C; Luís ML
Amyloid; 2002 Jun; 9(2):126-33. PubMed ID: 12440485
[TBL] [Abstract][Full Text] [Related]
38. Cardiac autonomic function does not improve after liver transplantation for familial amyloidotic polyneuropathy.
Wiklund U; Hörnsten R; Olofsson BO; Suhr OB
Auton Neurosci; 2010 Aug; 156(1-2):124-30. PubMed ID: 20478749
[TBL] [Abstract][Full Text] [Related]
39. The influence of the explant technique on the hemodynamic profile during sequential domino liver transplantation in familial amyloid polyneuropathy patients.
Escobar B; Taura P; Barreneche N; Beltran J; Balust J; Martinez-Palli G; Zavala E; Escorsell A; Garcia-Valdecasas JC
Liver Transpl; 2009 Aug; 15(8):869-75. PubMed ID: 19642136
[TBL] [Abstract][Full Text] [Related]
40. Risk of transmission of systemic transthyretin amyloidosis after domino liver transplantation.
Lladó L; Baliellas C; Casasnovas C; Ferrer I; Fabregat J; Ramos E; Castellote J; Torras J; Xiol X; Rafecas A
Liver Transpl; 2010 Dec; 16(12):1386-92. PubMed ID: 21117248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
